SHFHOTCPerfumes, Cosmetics & Other Toilet PreparationsUS GAAP · USD

Scientist Home Future Health Ltd

Scientist Home Future Health Ltd is a Nevada-based company that operates through its Hong Kong subsidiary, Scientist Home HK, in the retail trading of health supplements and topical creams. The business is organized around sourcing consumer health products and selling them through retail channels in Asia, with an investment-holding layer above the operating subsidiary.

Liikevaihto0,2milj. USD
Liikevoitto (EBIT)−0,2milj. USD
EBIT-marginaali−113,6%
Nettotulos−0,2milj. USD
Vapaa kassavirta−0,3milj. USD

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2025–2025

−0,3−0,2−0,10,00,10,20,3milj. USD2025: 0,20 milj. USD2025: EBIT −0,23 milj. USD20250,20−0,23
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Scientist Home Future Health Ltd

Liiketoiminta

Osuus liikevaihdosta
Health supplements60 %

Oral wellness products sold for preventive care and general health support.

Topical creams40 %

Creams and ointments sold for localized relief and recovery support.

Tuotteet

Raportoitu · osuus liikevaihdosta
30,6%24,2%22,2%11,5%FY2025100 %
  • Scientist Home Mixed Gelatine Hydrolysate30,6 %
  • Others Delivery Fee24,2 %
  • Scientist Home High Concentration Proteinase22,2 %
  • Scientist Home Vein Cream11,5 %
  • Scientist Home Cholipolysis Cholic Acid6,8 %
  • Scientist Home Bone Gelatine Hydrolysate4,8 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company sells to health-conscious consumers seeking natural wellness products, preventive care, and relief from chronic conditions. It also serves older customers managing age-related issues, as well as professionals and athletes looking for products that may help with muscle strain, soreness, or minor injuries.

Health-conscious consumers

Buy supplements and topical products for general wellness and natural health support.

Preventive care customers

Purchase products aimed at maintaining health and addressing symptoms early.

Elderly and chronic-condition users

Use topical creams and supplements for age-related discomfort and ongoing care.

Active lifestyle customers

Buy products for muscle strain, soreness, and minor injury recovery.

Strategia

The company’s strategy is to build a consumer health and wellness retail business around supplements and topical products, with an emphasis on natural and long-term health solutions. It also appears to rely on a principal-distributor model, giving it control over pricing, inventory, and customer fulfillment for the products it sells.

Expand consumer wellness product salesKeskipitkä aikaväli

Broader product adoption supports scale in a niche retail health business.

Strengthen distribution and pricing controlLyhyt aikaväli

Control over pricing and inventory helps protect product availability and margins.

Build presence in Asian consumer marketsKeskipitkä aikaväli

The business is operationally concentrated in Hong Kong and broader Asia.

Maantiede

Q1/2025

The operating business is centered in Hong Kong, while the parent company is incorporated in Nevada and the holding company is in the Marshall Islands. Management describes the business as primarily focused in Asia, so the company’s commercial exposure is tied to Asian consumer demand and Hong Kong-based operations.

Hong Kong100 %

Riskit

The company is exposed to small-scale operating risk, including dependence on a limited product set, inventory obsolescence, and customer demand for discretionary wellness products. It also faces related-party and governance risk because key funding and structural transactions involve insiders, while its principal-distributor model creates exposure to supplier pricing and supply continuity.

Järjestetty vakavuuden mukaan
Inventory obsolescenceKorkea

Supplements and creams can expire or become unmarketable if demand slows.

Kohdistuu: Inventory write-downs and gross margin volatility

Related-party dependenceKorkea

The company acquired a holding entity from its CEO and received advances from related parties.

KohdistuuGovernanceFinancingConflict-of-interest risk
Supplier pricing and supply riskKeskitaso

The distributor agreement allows the supplier to revise prices and affects product availability.

Kohdistuu: Cost of sales and product continuity

Concentrated operating footprintKeskitaso

Operations are primarily in Hong Kong and Asia, limiting geographic diversification.

KohdistuuRegional demandRegulatoryLogistics risk
Kysy Clarifolta: Scientist Home Future Health Ltd

Kirjanpito

Harkinnanvaraiset erät
Inventory obsolescence

Management must estimate shelf life and net realizable value for supplements and creams.

Vaikutus: Can trigger inventory write-downs and reduce gross profit

Expected credit loss

Receivables may require allowance estimates under US GAAP.

Vaikutus: Affects asset valuation and bad debt expense

Revenue recognition

Retail sales are recognized at the point control transfers to the customer.

Vaikutus: Affects timing of revenue and period comparability

Operating leases

Hong Kong office leases create right-of-use assets and lease liabilities.

Vaikutus: Affects balance sheet leverage and occupancy expense

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 29.4.2026

Scientist Home Future Health Ltd (OTC) – Perfumes, Cosmetics & Other Toilet Prepa | Analyysi – Clarifo